Generation and evaluation of a monoclonal antibody, designated MAdL, as a new specific marker for adenocarcinomas of the lung.
Br J Cancer
; 105(5): 673-81, 2011 Aug 23.
Article
in En
| MEDLINE
| ID: mdl-21811254
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Adenocarcinoma
/
Biomarkers, Tumor
/
Lung Neoplasms
/
Antibodies, Monoclonal
Type of study:
Diagnostic_studies
/
Evaluation_studies
/
Prognostic_studies
/
Screening_studies
Limits:
Animals
/
Female
/
Humans
Language:
En
Journal:
Br J Cancer
Year:
2011
Document type:
Article
Affiliation country:
Germany
Country of publication:
United kingdom